Clinical trial

Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA

NCT00653042

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Nesiritide Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-03-01

PhasePHASE2

Conditions

Coronary Artery Bypass Surgeryunresolved

Coronary Heart Diseaseverified · MONDO: coronary artery disorder

Coronary Artery Bypass Graftingunresolved

Cardiopulmonary Bypassunresolved

Ischemic Heart Diseaseverified · MONDO: myocardial ischemia

Congestive Heart Failureverified · MONDO: congestive heart failure

Interventions

NesiritideDRUG

Sponsors & collaborators

Scios, Inc.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00653042 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.